Journal of Liver Cancer

Aims & Scope

Journal of Liver Cancer (J Liver Cancer, JLC) is the official journal of the Korean Liver Cancer Association (KLCA, https://livercancer.or.kr/eng/index.php).

The aim of JLC is to provide a forum for medical doctors and basic scientists working in the field of liver cancer.

Its regional scope is mainly Korea, but it welcomes submissions from researchers all over the world.

The journal covers basic, translational and clinical research on liver cancer, including its molecular and cellular biology, pathophysiology, etiology, epidemiology, prevention, surveillance, diagnosis, and treatment.

JLC publishes articles in the form of original articles, case reports, review articles, and editorials.

All submitted manuscripts are peer reviewed.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

  Citation: 95

  Authors:

• Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide

  Citation: 87

  Authors: Do Young

• Histopathological Variants of Hepatocellular Carcinomas: an Update According to the 5th Edition of the WHO Classification of Digestive System Tumors

  Citation: 53

  Authors: Haeryoung, Mi, Young Nyun

• The General Rules for the Study of Primary Liver Cancer

  Citation: 31

  Authors: Jae Young, June Sung, Hyung-Joon, Jae-Jun, Ji Hoon, Bo Hyun, Choon Hyuck, Seung Duk, Hae Won, Jung Hoon, Woo Kyoung, Jin-Young, Heung Kyu, Dong Ho, Haeryoung, Baek-hui, Sang Min, Won Sup, Soon Ho

• Non-alcoholic fatty liver disease-related hepatocellular carcinoma

  Citation: 30

  Authors: Darine, Karim Seif El, Amit G.

• Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry

  Citation: 26

  Authors: Jun Sik, Han Ah, Hwi Young, Dong Hyun, Dong Ho, Suk Kyun, Ju-Yeon, Jonggi, Young, Hyun-Joo, Eunyang, Young-Joo, Jeong-Hoon

• Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association

  Citation: 21

  Authors: Yuri, Jin Woo, Hoon, Kun Yung, Byung Chan, Hee Ho, Dong Hyeon, Han Ah, Gyoung Min, Jung Suk, Dongho, In Joon, Hyunchul

• Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry

  Citation: 21

  Authors: Young Eun, Han Ah, Jun Sik, Jun Yong, Bo Hyun, In Joon, Suk Kyun, Dong Hyeon, Hyun-Joo, Eunyang, Young-Joo, Jeong-Hoon

• A clinical and pathological update on hepatocellular carcinoma

  Citation: 21

  Authors: Salvatore Lorenzo, Luca Di

• Radioembolization for hepatocellular carcinoma: what clinicians need to know

  Citation: 21

  Authors: Jin Woo, Hyo-Cheol